- Opsens press release ( OTCQX:OPSSF ): Q3 GAAP EPS of -$0.03.
- Revenue of $10.1M (+9.8% Y/Y) beats by $3.01M .
- Industrial sales increased 22% to $0.9 million in the third quarter of 2022, compared to $0.7 million in the third quarter of 2021.
-
Sales of optical medical products, including the supply agreement with Abiomed, totaled $2.6 million in the third quarter of 2022, compared to $2.3 million in the third quarter of 2021.
- Net loss was $2.9 million in the third quarter of 2022, compared to $570,000 in the third quarter of 2021.
-
OpSens had a cash position of $28 million as of May 31, 2022, compared to $38.6 million as of August 31, 2021.
For further details see:
Opsens GAAP EPS of -$0.03, revenue of $10.1M beats by $3.01M